
Treatment-induced malignancies in head and neck cancer survivors exhibit poorer outcomes due to limited therapeutic options and aggressive nature. Identifying high-risk groups for such secondary cancers is critical to improving survival. A review summarized risk factors, histological insights, diagnostic approaches, and follow-up strategies, emphasizing lifelong care and personalized treatment. Future perspectives include enhancing diagnostic accuracy and targeted therapies to address these malignancies effectively.
Like
Save
Share